Claritev (NYSE:CTEV) SVP William Mintz Purchases 916 Shares

Claritev (NYSE:CTEV) SVP William Mintz purchased 916 shares of the firm’s stock in a transaction dated Monday, November 17th. The shares were bought at an average cost of $38.00 per share, with a total value of $34,808.00. Following the transaction, the senior vice president directly owned 65,325 shares of the company’s stock, valued at approximately $2,482,350. This represents a 1.42% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Claritev Stock Up 10.3%

CTEV traded up $4.34 during trading on Wednesday, hitting $46.63. The company had a trading volume of 385,003 shares, compared to its average volume of 135,310. Claritev has a 1-year low of $5.39 and a 1-year high of $74.07. The company has a debt-to-equity ratio of 310.26, a current ratio of 1.21 and a quick ratio of 1.21. The company has a market cap of $770.61 million, a PE ratio of -2.23 and a beta of 0.42. The business has a 50-day moving average of $57.41 and a 200-day moving average of $49.25.

Analysts Set New Price Targets

Several brokerages have recently commented on CTEV. Citigroup increased their price target on shares of Claritev from $74.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Weiss Ratings restated a “sell (d-)” rating on shares of Claritev in a research note on Tuesday. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, Claritev presently has a consensus rating of “Hold” and an average target price of $80.00.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. Ameritas Investment Partners Inc. bought a new stake in Claritev during the 3rd quarter valued at $42,000. Legal & General Group Plc acquired a new position in shares of Claritev during the third quarter valued at $45,000. BNP Paribas Financial Markets bought a new stake in shares of Claritev during the third quarter valued at about $79,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Claritev during the third quarter valued at about $187,000. Finally, Jacobs Levy Equity Management Inc. acquired a new stake in Claritev in the third quarter worth about $322,000. 87.15% of the stock is owned by institutional investors and hedge funds.

Claritev Company Profile

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.